As part of its ongoing commitment to cardiac care, Abrazo Arizona Heart Hospital has opened a new Institute for Congestive Heart Failure, offering comprehensive, personalized care to heart failure patients in the Phoenix area.
Heart disease, which includes congestive heart failure, is the leading cause of death for both men and women in the United States, according to the Centers for Disease Control and Prevention.
The Institute for Congestive Heart Failure encompasses everything from prevention and early detection to an array of treatment options, including optimized medications and revolutionary, minimally invasive cardiac procedures. It also includes a Cardiorenal Outpatient Center, where patients can receive treatment for heart and kidney conditions. In many cases, doctors and hospitals treat heart and kidney conditions separately even though one can exacerbate the other. At the dedicated Cardiorenal Center, Abrazo caregivers address both conditions as one.
While heart failure may involve frequent visits to a hospital, Dr. Kris Vijay, the Institute's medical director, is optimistic about helping patients manage their heart disease to avoid hospitalization.
"Heart failure conjures up a thought that death is imminent, but nothing could be further from the truth," said Dr. Vijay. “On the contrary, heart failure patients can enjoy long and healthy lives, thanks in part to advancements in cardiovascular care."
The Institute for Congestive Heart Failure is one of six specialty cardiac and vascular institutes at Abrazo Arizona Heart Hospital. In addition, the hospital has a Certified Chest Pain Center with Primary Percutaneous Coronary Intervention Accreditation by the American College of Cardiology, involved in more than two dozen national clinical trials on heart and cardiovascular conditions, and serves as a training ground for cardiologists nationwide.